Decreased PIBF1/IL6/p-STAT3 during the mid-secretory phase inhibits human endometrial stromal cell proliferation and decidualization

Mingjuan Zhou,Huihui Xu,Dan Zhang,Chenchen Si,Xiaowei Zhou,Hui Zhao,Qiang Liu,Bufang Xu,Aijun Zhang

DOI: https://doi.org/10.1016/j.jare.2020.09.002

IF: 12.822

2021-05-01

Journal of Advanced Research

Abstract:Recurrent implantation failure (RIF) is a challenging problem of assisted reproductive technology that arises mainly due to inadequate endometrial receptivity and its pathogenesis is still unclear. In this study, microarray assay, reverse transcriptase-quantitative polymerase chain reaction, western blot, and <em>in-vitro</em> experiments were conducted. The results showed that progesterone-induced blocking factor 1 (PIBF1) expression was highest in the mid-secretory endometrium in control subjects, but was significantly lower in RIF patients. In Ishikawa and human endometrial stromal cells (HESCs), rather than human endometrial epithelial cells, PIBF1 knockdown significantly downregulated cell proliferation and the levels of interleukin 6 (IL6) and phosphorylated signal transducer and activator of transcription-3 (p-STAT3). Besides, in HESCs, the levels of IL6, p-STAT3, prolactin and insulin-like growth factor binding-protein-1 (IGFBP1) decreased after PIBF1 knockdown during <em>in-vitro</em> decidualization. All these cellular changes could be notably restored by PIBF1 or IL6 overexpression. Consistent with our findings with PIBF1, the levels of IL6, p-STAT3, ki-67, prolactin, and IGFBP1 in the mid-secretory endometrium were notably lower in patients with RIF compared with controls. In summary, in the mid-secretory phase, decreased expression of PIBF1, IL6, and p-STAT3 inhibited HESC proliferation and decidualization, which is of theoretical and clinical importance for future research and clinical-treatment strategies.<span class="display"><span><ol class="links-for-figure"><li><a class="anchor download-link u-font-sans" href="https://ars.els-cdn.com/content/image/1-s2.0-S2090123220302125-ga1_lrg.jpg"><span class="anchor-text">Download : <span class="download-link-title">Download high-res image (238KB)</span></span></a></li><li><a class="anchor download-link u-font-sans" href="https://ars.els-cdn.com/content/image/1-s2.0-S2090123220302125-ga1.jpg"><span class="anchor-text">Download : <span class="download-link-title">Download full-size image</span></span></a></li></ol></span></span>

multidisciplinary sciences

What problem does this paper attempt to address?

The problem that this paper attempts to solve is how the decreased expression of Progesterone - Induced Blocking Factor 1 (PIBF1) affects the receptivity and decidualization ability of the endometrium in patients with Recurrent Implantation Failure (RIF). Specifically, the study focuses on the expression changes of PIBF1 in the mid - secretory phase of the endometrium and its impact on the proliferation and decidualization of Human Endometrial Stromal Cells (HESCs). By exploring the relationship between PIBF1 and the IL6/p - STAT3 signaling pathway, it reveals whether the decreased PIBF1 expression is one of the reasons for the poor endometrial receptivity in RIF patients.

### Research Background
Recurrent Implantation Failure (RIF) refers to the situation where clinical pregnancy has not been achieved after at least three embryo transfers and at least four high - quality embryos have been transferred during in vitro fertilization and embryo transfer (IVF - ET). The incidence of RIF is approximately 10% and is a challenging problem in assisted reproductive technology. Currently, the specific pathogenesis of RIF is still unclear, but studies have shown that endometrial receptivity and embryo quality are the main factors affecting embryo implantation efficiency, and the insufficiency of endometrial receptivity is considered to be the main cause of RIF.

### Research Objectives
This study aims to explore the expression changes of PIBF1 in the mid - secretory phase of the endometrium and how these changes affect the proliferation and decidualization processes of HESCs. By analyzing the relationship between PIBF1 and the IL6/p - STAT3 signaling pathway, the researchers hope to reveal whether the decreased PIBF1 expression is the key factor leading to the poor endometrial receptivity in RIF patients.

### Main Findings
1. **Expression pattern of PIBF1**: In the normal control group, the mRNA and protein levels of PIBF1 reach their peaks in the mid - secretory phase of the endometrium, while in RIF patients, the PIBF1 expression in this period is significantly decreased.
2. **Effect of PIBF1 on cell proliferation and decidualization**: In Ishikawa cells and HESCs, PIBF1 knockdown significantly inhibits cell proliferation and the expression of IL6 and p - STAT3. In addition, PIBF1 knockdown also reduces the expression of PRL and IGFBP1 in HESCs, which are markers of decidualization.
3. **Effect of PIBF1 over - expression**: PIBF1 over - expression can restore the expression of IL6, p - STAT3 and cell proliferation in HESCs, further confirming the important role of PIBF1 in regulating HESCs functions.

### Conclusions
The research results show that in the mid - secretory phase of the endometrium, the decreased PIBF1 expression inhibits the proliferation and decidualization of HESCs by suppressing the IL6/p - STAT3 signaling pathway, which may be one of the important reasons for the poor endometrial receptivity in RIF patients. This finding provides a theoretical basis for future research and clinical treatment strategies.